Refer to a Hopkins Colleague

 

Continuing Medical Education

 

Case Rounds

 

Observerships & Visits

 

Videoconferences

 

Events and Seminars

 

Publications

 

Services for Your Institution

 

Medical News from Johns Hopkins

 

Contact Us


 

International Physician Update

HOPKINS DOCTORS CIRCLE THE GLOBE  
January 2005  





Ian McNiece, Ph.D., Appointed Director of Division of Biomedical Sciences, Johns Hopkins in Singapore

 McNiece180  
Ian McNiece is renowned as a stem cell researcher.  
   

Ian McNiece, Ph.D., has been selected to chair the new Division of Biomedical
Sciences, Johns Hopkins in Singapore (DJHS). Since 2003, McNiece has been based in Baltimore, Maryland, where he is professor of oncology, and also serves as director of the Graft Engineering Laboratory at Johns Hopkins Medicine. DJHS is the first academic division of Johns Hopkins School of Medicine based outside
Baltimore.

DJHS has recently embarked on an ambitious growth plan that will include 12 full-time Johns Hopkins faculty based in Singapore to lead training and research initiatives in biomedical science disciplines such as immunology, cellular therapy, cancer biology and experimental therapeutics. Within two years, DJHS plans to build a staff of 150 research professionals.

The new Johns Hopkins division also will offer graduate training (Ph.D. programs) in basic and clinical research to Singaporeans and other Southeast nationals. The Ph.D. training conducted in Singapore and Baltimore will lead to either a Hopkins Ph.D. or National University of Singapore (NUS) Ph.D. degree.

“With this appointment, we are bringing Hopkins’ relationship with the Singaporean scientific community to a new and higher level,” said Edward D. Miller, M.D., dean and CEO of Johns Hopkins Medicine. The relationship of Johns Hopkins with the scientific community of Singapore started in 1998.

“Now that we have a full-fledged division of our School of Medicine, we felt that Ian was the best candidate to bring the highest standards of Hopkins research to this new endeavor. His experience in translational research will be key to make the venture succeed.”

McNiece is internationally renowned for his contributions as a researcher in stem cell biology and clinical marrow and stem cell transplantation. He trained at Melbourne University in Australia, where he received his B.Sc. in biochemistry (1979), and M.Sc. (1981) and Ph.D. (1986) degrees in physiology.

He completed his thesis work at the Peter MacCallum Cancer Institute in Melbourne. McNiece subsequently came to the United States as a postdoctoral fellow at the University of Virginia. In 1988, he joined Amgen Inc., Thousand Oaks, California, as a research scientist and became laboratory head in the Department of Developmental Hematology in 1994. In 1995, he was appointed to head the Amgen Central Laboratory at Saint Luc University Hospital in Belgium.

Before joining Johns Hopkins Medicine, as a professor, McNiece worked at the University of Colorado Health Science Center where he was director of research for the Bone Marrow Transplant Program and director of the Stem Cell Biology Program.

 
 
Back to top
2006 | All Rights Reserved | Johns Hopkins University and Health System
601 North Caroline Street, Baltimore, Maryland 21287-0765 USA
Contact Us | Johns Hopkins Medicine